Intrust Bank’s TriSalus Life Sciences TLSI Stock Holding History

Intrust Bank’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-66,000	Closed	-$264K	–	432
2026 Q1	$264K	Buy	+66,000	New	+$323K	0.02%	373

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Intrust Bank's TLSI Position: Q2 2026 in Review

Intrust Bank sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 66,000 shares — an estimated $264K sold.

Intrust Bank first reported a position in TLSI in Q1 2026 and held it in 1 quarter. The position peaked at $264K in Q1 2026. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Intrust Bank reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
Intrust Bank sold 66,000 TriSalus Life Sciences shares in Q2 2026, an estimated $264K.
Intrust Bank first reported a position in TriSalus Life Sciences in Q1 2026 and held it in 1 quarter.
Intrust Bank's TriSalus Life Sciences position peaked at $264K in Q1 2026.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.